Advertisement

Topics

Kisqali outperformed stand-alone hormonal therapy against breast cancer

04:55 EST 9 Nov 2017 | SmartBrief

A late-stage trial of Novartis' breast cancer drug Kisqali in combination with hormonal therapies in premenopausal women was  -More

Original Article: Kisqali outperformed stand-alone hormonal therapy against breast cancer

NEXT ARTICLE

More From BioPortfolio on "Kisqali outperformed stand-alone hormonal therapy against breast cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...